HomeInsights52 Week Low Stocks

Beta Drugs Ltd 52 Week Low

Beta Drugs Ltd 52 Week Low

stocks purchased

₹ 1.8 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

9.0 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Beta Drugs Ltd

NSE: BETA

YEARLOW

₹ 1060.05

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week Low of Beta Drugs Ltd is ₹ 1060 as of 26 Dec 24 .

Company Fundamentals for Beta Drugs Ltd

No data available

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 20242020
24 Dec 20241948.85
23 Dec 20242016.7
20 Dec 20242060.05
19 Dec 20242127
18 Dec 20242124.5
17 Dec 20242124.5
16 Dec 20242085.95
13 Dec 20242171.25
12 Dec 20242199.45

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Beta Drugs Ltd News Hub

News

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

28 Nov 2024 15:41

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 2024 14:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 2024 13:59

News

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be hel...

Read more

02 Sep 2024 17:17

News

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2024 Pow...

Read more

07 May 2024 12:58

News

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2023...

Read more

01 Nov 2023 16:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Beta Drugs Ltd

Why is it important to track the 52-week low of Beta Drugs Ltd stocks?

Investors should monitor the 52-week low of Beta Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Beta Drugs Ltd stocks hitting a 52-week low?

Factors leading to Beta Drugs Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Beta Drugs Ltd stocks when they hit a 52-week low?

Buying Beta Drugs Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Beta Drugs Ltd stocks?

Investors should monitor the 52-week low of Beta Drugs Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Beta Drugs Ltd stock at their 52-week low?

An investor can analyze the reasons for the Beta Drugs Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Beta Drugs Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Beta Drugs Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Beta Drugs Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions